Navigation Links
Global Non-Hematological Cancers Market to Hit $140.8 Billion by 2021, says GBI Research
Date:4/8/2016

LONDON, April 8, 2016 /PRNewswire/ --

A new report from business intelligence provider GBI Research - Global Non-Hematological Cancers Market to 2021 - states that the global treatment market for non-hematological cancers, which includes breast, colorectal, lung and prostate cancers, among others, will almost double from $72.9 billion in 2014 to $140.8 billion in 2021, at a compound annual growth rate (CAGR) of 9.9%.

This robust growth will occur in spite of the patent expiries of a number of very commercially successful products, including Avastin, Erbitux and Herceptin. Avastin will see its first expiry in the EU in 2018, with the two others having already experienced EU expiries in 2014.

Associate Analyst Adam Bradbury explains: "These drugs are all monoclonal Antibodies (mAbs), and are therefore expected to be less susceptible to market share and price erosion following patent expiry, due to practical and regulatory barriers to entry for biosimilars. In this way, these expirations will not pose too strong a barrier to growth."

Market drivers will include the increasing prevalence of cancer globally, and the introduction of more targeted treatments, which will improve the overall survival of poor-performance-status patients and enable more rounds of chemotherapy to be administered.

GBI Research also states that in terms of the pharmaceutical pipeline for non-hematological cancers, there are 2,954 products in active development, 171 of which are in Phase III development or Pre-registration.

Bradbury explains: "Although none of the products in the late-stage pipeline are expected to reach the same levels of success as the highest revenue-generating drugs currently in the market, due to the competitiveness of the landscape, there are a number of candidates that are expected to achieve strong sales during the forecast period. These include AZD-4736 and neratinib, which are both forecast to generate blockbuster revenues by 2021.

"A range of companies are actively involved in the development or marketing of these new oncology products, including most of the top 20 pharmaceutical companies, smaller publicly traded companies and privately-held enterprises. In particular, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, and Novartis, are anticipated to maintain their strong market shares throughout the forecast period.

"While Roche's market share within non-blood cancers is anticipated to decrease, partly due to the approaching patent expiries of Avastin and Tarceva, Roche is still expected to maintain the highest market share for non-hematological cancer treatment of any company throughout the forecast period."

Sample pages of GBI Research's report Global Non-Hematological Cancers Market to 2021 are available upon request

About GBI Research 

GBI Research is a leading provider of business intelligence reports, offering actionable data and forecasts based on the insights of key healthcare industry influencers to ensure you stay up-to-date with the latest market trends. For more information about our offerings, please contact us on:

+44-(0)161-359-5817 

Connect with GBI Research on social media for the latest healthcare market updates:

Facebook | LinkedIn | Twitter


'/>"/>
SOURCE GBI Research
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Alzheimer Disease Report 2016 - New Drugs, Markets and Companies to 2025 Featuring 300+ Different Compounds at Various Stages of Development - Research and Markets
2. Global Nitric Oxide Therapeutics, Markets and Companies Study 2016 with Projections to 2020 & 2025 - Research and Markets
3. Global Animal Biotechnology Technologies, Markets and Companies Report 2016 - Research Activities of 11 Veterinary and Livestock Research Institutes With 108 Collaborations - Research and Markets
4. Global Gene Therapy Technologies, Markets and Companies Report 2016 - Analysis & Forecasts 2015-2025 - Research and Markets
5. Global Medication Adherence Market Expected to Grow With 17.5% CAGR During 2016-2022: P&S Market Research
6. Global Ultrasound Market Growth Steady at 5.5% CAGR to 2020
7. Global Age-Related Macular Degeneration Market Expected to Grow at 7.6% CAGR During 2016-2022: P&S Market Research
8. Global HCV Market: Gilead Sciences, AbbVie, J&J and Bristol-Myers Squibb Featured in 2016 Hepatitis C Virus Edition Report
9. Knee Cartilage Repair Market Projected to Reach US$ 2.7 Billion Globally in 2023: Transparency Market Research
10. Global Blood Therapeutics Reports Recent Business Progress and Provides Fourth Quarter and Year-End 2015 Financial Results
11. Peripheral Neuropathy (Sensory) Market Pipeline Global Review H2 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2020)... ... September 02, 2020 , ... Rigaku ... a roundtable discussion among industry professionals about successes and challenges of making changes ... American Pharmaceutical Review and will take place on October 15, 2020 at ...
(Date:9/1/2020)... ... September 01, 2020 , ... Mara C. Weinstein Velez, M.D., ... the University of Rochester Medical Center, in Upstate New York. She completed a ... clinical faculty from the Harvard and Yale Departments of Dermatology and is one ...
(Date:9/1/2020)... ... September 01, 2020 , ... September is National Ovarian Cancer Awareness ... deaths than any other cancer of the female reproductive system. The American Cancer ... and about 14,000 women will die from this disease. Throughout the month of ...
Breaking Medicine Technology:
(Date:8/31/2020)... ... August 31, 2020 , ... ... management solution for chiropractors, announced today the launch of its integrated, HIPAA compliant, ... start running their virtual practice in under 90 seconds. , According to ...
(Date:8/31/2020)... ... 2020 , ... The pandemic and topsy-turvy economic outlook continues to put financial strain on many ... to trim the fat from our monthly expenses and put more into savings, if possible. ... you have a financial safety net in place in case something were to happen to ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang ... persons with autism and other developmental disabilities, as well as supporting staff in ... adolescents with autism, school consultation, and staff development. She joined the company in ...
(Date:8/28/2020)... ... August 28, 2020 , ... Ernst & ... was named an Entrepreneur Of The Year® 2020 Florida Award finalist. Now in ... whose ambitions deliver innovation, growth and prosperity as they build and sustain successful ...
(Date:8/28/2020)... ... 28, 2020 , ... With in-person gluten-free events being canceled ... the specialty-diet community connect with great, gluten-free brands. At the Online Nourished ... with brands & watch over 50 educational classes... all online from the comfort ...
Breaking Medicine News(10 mins):